| Patents for C07J 3 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by one carbon atom (1,033) |
|---|
| 09/07/2007 | WO2007099548A2 Novel 11 beta - hydroxyandrosta-4-ene-3-ones |
| 09/07/2007 | CA2637548A1 Novel 11 beta - hydroxyandrosta-4-ene-3-ones |
| 08/28/2007 | US7262023 synthesis of steroids by hydroxylation and oxidation with use of microoganisms; biosynthesis |
| 08/23/2007 | US20070197489 Composition of matter |
| 08/09/2007 | WO2006072600A8 Androstane 17-alpha-carbonate for use in the treatment of inflammatory and allergic conditions |
| 07/18/2007 | CN100999541A Synthesizing process of fluorine propionate ticasone |
| 06/21/2007 | US20070142345 Steroids for cancer treatment |
| 06/14/2007 | US20070135400 Estradiol derivatives |
| 06/13/2007 | EP1794176A2 2-substituted estrogen sulphamates for inhibition of steroid sulphatase |
| 05/24/2007 | WO2007057152A1 17.beta.-fluoromethoxycarbonyl-androst-4-en-3-one compounds with a 17.alpha.-carbonate substituent |
| 05/22/2007 | CA2276694C New fatty acid derivatives |
| 05/16/2007 | CN1315867C 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents |
| 05/16/2007 | CN1315864C Oxidation process for preparing the intermediate 6alpha, 9alpha-difluoro-11beta, 17alpha-dihydroxy-16.alpha-methyl-androst-1, 4-dien-3-one-17beta-carboxylic acid |
| 05/02/2007 | EP1226155B1 18-nor-steroids as selectively active estrogens |
| 04/24/2007 | US7208613 Treating 17 beta -[(N,N-dimethylcarbamoyl)thio]carbonyl-6 alpha ,9 alpha-difluoro-11-beta -hydroxy-16 alpha-methyl-17-alpha -propionyloxy-3-oxoandrosta-1,4-diene with an alkali metal carbonate-alcohol system and reacting the product with bromofluoromethane |
| 04/03/2007 | US7199115 inhibitors for 5 alpha -reductase; high potency gestagens; conditions caused by high levels of androgens; acne, hirsutism, alopecia (male type), BPH (benign prostatic hyperplasia) and prostate carcinoma; contraceptives for men and women; (E)-17 alpha -fluoro-3-oxo-estra-4-en-17 beta-carbaldehyde oxime |
| 03/07/2007 | CN1923841A 7 alpha-substituted 11 alpha-hydroxysteroids and its microbiological production method |
| 02/27/2007 | CA2425849C Angiostatic steroids |
| 02/22/2007 | US20070043007 Specific glucocorticosteroid compounds having anti-inflammatory activity |
| 02/15/2007 | US20070037782 Therapeutic agent for ageing macular degeneration |
| 02/01/2007 | US20070027128 comprising a drug compound 6 alpha ,9 alpha -Difluoro-17 alpha -[(2-furanylcarbony)oxy]-11 beta -hydroxy-16 alpha -methyl-3-oxo-androsta-1,4-diene-17 beta -carbothioic acid S-fluoromethyl ester; dry powder inhaler; with predictable pharmacokinetic and pharmacodynamic behaviour |
| 01/31/2007 | CN1903871A Synthesis method of fluoticarson propionate |
| 01/11/2007 | US20070010505 Methods of treating disease states using antiangiogenic agents |
| 01/10/2007 | EP1392320B1 17-METHYLENE-ANDROSTAN-3a-OL ANALOGS AS CRH INHIBITORS |
| 01/10/2007 | CN1294142C 17 beta-carbothioate 17 alpha-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents |
| 01/04/2007 | WO2005077968B1 17-methylene-or 17 - spiro - cyclopropane 7 - substituted estra - 1, 3, 5 (10) - triene derivatives with anti - estrogenic activity |
| 01/02/2007 | CA2168850C Estrogenic compounds as anti-mitotic agents |
| 12/05/2006 | US7144845 Compounds useful in the manufacture of an anti-inflammatory androstane derivative |
| 11/16/2006 | WO2005077968A8 17-methylene-or 17 - spiro - cyclopropane 7 - substituted estra - 1, 3, 5 (10) - triene derivatives with anti - estrogenic activity |
| 11/07/2006 | US7132532 Compounds useful in the manufacture of an anti-inflammatory androstane derivative |
| 11/02/2006 | US20060247434 Method for the preparation of 6-alpha fluoro corticosteroids |
| 11/02/2006 | US20060247219 Specific glucocorticosteriod compound having anti-inflamatory activity |
| 11/02/2006 | EP1716166A2 17-methylene- or 17-spiro-cyclopropane 7-substituted estra-1,3,5(10)-triene derivatives with anti-estrogenic activity |
| 10/25/2006 | CN1850843A Method for removing carbonylazathia acetal protection group |
| 10/24/2006 | US7125985 Compounds useful in the manufacture of an anti-inflammatory androstane derivative |
| 10/18/2006 | EP0914165B1 Steroids as neurochemical stimulators of the vno to alleviate symptoms of pms |
| 10/18/2006 | CN1849330A Specific glucocorticosteroid compound having anti-inflammatory activity |
| 10/18/2006 | CN1849125A Therapeutic agent for ageing macular degeneration |
| 10/11/2006 | EP1471896B1 Formulations for inhalation |
| 10/11/2006 | CN1845933A Specific glucocorticosteriod compound having anti-inflamatory activity |
| 09/27/2006 | CN1837231A Immunomodulatory steroids, in particular the hemihydrate of 16, alpha-bromoepiandrosterone |
| 09/21/2006 | US20060211857 6,7-Oxygenated steroids and uses related thereto |
| 09/19/2006 | US7109187 Estrogenic compounds as anti-mitotic agents |
| 09/13/2006 | CN1274708C Process for connecting side chain to androstane compound at 17th position |
| 08/31/2006 | WO2006072599A3 Androstane 17-alpha carbonate derivatives for use in the treatment of allergic and inflammatory conditions |
| 08/31/2006 | WO2005077968A3 17-methylene-or 17 - spiro - cyclopropane 7 - substituted estra - 1, 3, 5 (10) - triene derivatives with anti - estrogenic activity |
| 08/29/2006 | US7098328 Method for the preparation of 6α-fluoro corticosteroids |
| 08/24/2006 | WO2006032885A3 2-substituted estrogen sulphamates for inhibition of steroid sulphatase |
| 08/17/2006 | US20060183727 Estrogenic compounds as anti-mitotic agents |
| 07/13/2006 | WO2006072600A1 Androstane 17-alpha-carbonate for use in the treatment of inflammatory and allergic conditions |
| 07/13/2006 | WO2006072599A2 Androstane 17-alpha carbonate derivatives for use in the treatment of allergic and inflammatory conditions |
| 07/12/2006 | CN1263768C New taraxerol derivative and its preparation and use |
| 07/05/2006 | CN1798757A Process for the preparation of steroidal carbothioic acid derivatives and intermediates |
| 06/27/2006 | US7067682 6,7-Oxygenated steroids and uses related thereto |
| 06/14/2006 | EP1669075A1 Therapeutic agent for ageing macular degeneration |
| 06/14/2006 | CN1786014A Synthesis method of cortin |
| 06/01/2006 | US20060116418 Materials and methods for treating hypercholesterolemia |
| 06/01/2006 | US20060116359 17.Beta-(alpha-hydroxy)-esters of androstanes as intermediates for the preparation of 17.beta-fluorinated-androstane esters |
| 05/03/2006 | CN1254479C 3-methylene steroid derivative |
| 04/19/2006 | CN1252081C Intermediate for preparation of 16 Beta-methyl steroids |
| 04/12/2006 | EP1644398A1 Specific glucocorticosteroid compound having anti- inflammatory activity |
| 04/12/2006 | EP1644397A1 Specific glucocorticosteroid compound having anti- inflammatory activity |
| 04/04/2006 | US7022722 5-(ester-substituted benzyl or benzylidene)-thiazolidine-2,4-diones; readily metabolized by the physiological metabolic drug detoxification systems without loss of therapeutic benefit; lower side effects and toxicity in patients with elevated or compromised liver function |
| 03/30/2006 | WO2006032885A2 2-substituted estrogen sulphamates for inhibition of steroid sulphatase |
| 03/30/2006 | CA2576614A1 2-substituted estrogen sulphamates for inhibition of steroid sulphatase |
| 03/29/2006 | EP1640009A1 Estrogenic compounds as antimitotic agents |
| 03/23/2006 | US20060063749 immunomoderators ; bromo-3-hydroxyandrostan-17-one; antiallergens; rhinitis |
| 03/15/2006 | EP1633367A2 Antiangiogenic agents |
| 03/14/2006 | US7012070 Estrogenic compounds as anti-mitotic agents |
| 03/08/2006 | EP1240179B1 3-methylene steroid derivatives for the treatment of autoimmune diseases |
| 03/08/2006 | CN1244593C Preparation of fluometasone and its 17-carboxyl androstene analog |
| 03/07/2006 | US7009063 Process for the production of oxandrolone |
| 03/01/2006 | CN1243767C Immunomodulatory steroids, in particular hemihydrate of 16 alpha-bromoepiandrosterone |
| 01/11/2006 | CN1718586A Synthesis method of N-tertiary butyl-3-carbonyl-4-aza-5 alpha-androl-1-end-17 beta-formamide |
| 01/10/2006 | CA2425841C Angiostatic steroids |
| 01/04/2006 | EP1611149A1 Process for the preparation of steroidal carbothioic acid derivatives and intermediates |
| 12/22/2005 | US20050282732 immunology moderator; -bromoo-3-hydroxyandrostan-17-one with excipients; prevent viral reproduction |
| 12/21/2005 | EP0713393B1 Estrogenic compounds as anti-angiogenesis agents |
| 12/15/2005 | WO2005030120A3 Antiangiogenic agents |
| 11/17/2005 | US20050256325 Treating 17 beta -[(N,N-dimethylcarbamoyl)thio]carbonyl-6 alpha ,9 alpha-difluoro-11-beta -hydroxy-16 alpha-methyl-17-alpha -propionyloxy-3-oxoandrosta-1,4-diene with an alkali metal carbonate-alcohol system and reacting the product with bromofluoromethane |
| 11/17/2005 | US20050256095 using 6-bromo-3-hydroxtandrostan-17-one |
| 11/16/2005 | EP1594877A2 Process for the production of 2-oxa-3-one androstane derivatives |
| 10/25/2005 | US6958355 Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis |
| 10/20/2005 | US20050234027 (E)-17 alpha -fluoro-3-oxo-estra-4-en-17 beta -carbaldehyde oxime; male-type alopecia, acne and hirsutism, anticarcinogenic agents |
| 10/04/2005 | US6951877 Materials and methods for treating hypercholesterolemia |
| 09/27/2005 | US6949533 use in treating asthma, allergy, arthritis and thrombosis |
| 09/22/2005 | US20050209206 Pharmaceutical formulation comprising an androstane derivative and a solubilising agent in an aqueous liquid carrier |
| 09/21/2005 | CN1671858A Microbiological method for the production of 7 alpha-substituted 11 alpha-hydroxysteroids |
| 09/14/2005 | CN1666993A Steroid compounds preparation method |
| 09/01/2005 | US20050192437 Process for the preparation of 6alpha-fluoro steroids by isomerisation of 6beta-fluorosteroids |
| 08/31/2005 | EP1335928B1 Selective glucocorticoid receptor agonists |
| 08/25/2005 | WO2005077968A2 17-methylene-or 17 - spiro - cyclopropane 7 - substituted estra - 1, 3, 5 (10) - triene derivatives with anti - estrogenic activity |
| 08/25/2005 | CA2552843A1 Steroids for cancer treatment |
| 08/10/2005 | CN1214038C 9alpha-chloro-6alpha-fluoro-17alpha-16-methyl-17-beta-methoxy carbonyl-androst-1, 4-dienes esterified in position 17 alpha by a cyclic acyl proup |
| 07/28/2005 | US20050164997 a 3-oxo-androstancarbothioic acid compound; respiaratory system disorder |
| 07/26/2005 | US6921757 Conversion of carboxylic acid substituent in a gonane ring, into the methyl ester, or hydrochlorination of a 9-11-epoxy-9-H-cyclopenta(a)phenanthrene compounds |
| 07/21/2005 | US20050159366 a 6-bromo-3-hydroxyandrostan-17-one compound; viricides; immunosuppressants |
| 06/16/2005 | US20050130947 6alpha, 9alpha-Difluoro-17alpha-((2-furanylcarbonyl)oxy)-11beta-hydroxy-16alpha-methyl-3-oxo-androsta-1,4-diene-17beta-carbothioic acid S-fluoromethyl ester completely dissolved in a liquified hydrofluoroalkane (HFA) gas as propellant; for asthma or chronic obstructive pulmonary disease (COPD) |
| 06/08/2005 | EP1537068A1 Materials and methods for treating hypercholesterolemia |
| 06/01/2005 | EP1534733A2 Convenient synthesis of s-fluoromethyl 6alpha, 9alpha-difluoro-11beta-hydroxy-16alpha- methyl-17alpha-propionyloxy-3-oxoandrosta-1, 4-diene-17beta-carbothioate |